Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;8(5):445-52.
doi: 10.1016/j.jalz.2012.08.001.

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

Mary D Naylor  1 , Jason H Karlawish, Steven E Arnold, Ara S Khachaturian, Zaven S Khachaturian, Virginia M-Y Lee, Matthew Baumgart, Sube Banerjee, Cornelia Beck, Kaj Blennow, Ron Brookmeyer, Kurt R Brunden, Kathleen C Buckwalter, Meryl Comer, Kenneth Covinsky, Lynn Friss Feinberg, Giovanni Frisoni, Colin Green, Renato Maia Guimaraes, Lisa P Gwyther, Franz F Hefti, Michael Hutton, Claudia Kawas, David M Kent, Lewis Kuller, Kenneth M Langa, Robert W Mahley, Katie Maslow, Colin L Masters, Diane E Meier, Peter J Neumann, Steven M Paul, Ronald C Petersen, Mark A Sager, Mary Sano, Dale Schenk, Holly Soares, Reisa A Sperling, Sidney M Stahl, Vivianna van Deerlin, Yaakov Stern, David Weir, David A Wolk, John Q Trojanowski
Affiliations

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

Mary D Naylor et al. Alzheimers Dement. 2012 Sep.

Abstract

To address the pending public health crisis due to Alzheimer's disease (AD) and related neurodegenerative disorders, the Marian S. Ware Alzheimer Program at the University of Pennsylvania held a meeting entitled "State of the Science Conference on the Advancement of Alzheimer's Diagnosis, Treatment and Care," on June 21-22, 2012. The meeting comprised four workgroups focusing on Biomarkers; Clinical Care and Health Services Research; Drug Development; and Health Economics, Policy, and Ethics. The workgroups shared, discussed, and compiled an integrated set of priorities, recommendations, and action plans, which are presented in this article.

PubMed Disclaimer

References

    1. United States Department of Health and Human Services, Assistant Secretary for Planning and Evaluation. [Accessed May 16, 2012. 2012.];United States National Plan to Address Alzheimer's Disease. http://aspe.hhs.gov/daltcp/napa/NatlPlan.pdf.
    1. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov. 2010;9:203–214. - PubMed
    1. Cuatrecasas P. Pedro Cuatrecasas. Nat Rev Drug Discov. 2009;8:446. - PubMed
    1. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012;8:S1–68. - PMC - PubMed
    1. Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, Davatzikos C, Detre J, Gaulton G, Grossman M, Hurtig H, et al. Design of comprehensive Alzheimer's disease centers to address unmet national needs. Alzheimers Dement. 2010;6:150–155. - PMC - PubMed

Publication types